4//SEC Filing
Giuffre Randall Michael 4
Accession 0001235802-22-000135
CIK 0001401040other
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 4:34 PM ET
Size
8.8 KB
Accession
0001235802-22-000135
Insider Transaction Report
Form 4
Giuffre Randall Michael
Director
Transactions
- Purchase
Voting Common Shares, no par value per share
2022-12-09$1.43/sh+37,079$53,023→ 260,225 total - Purchase
Voting Common Shares, no par value per share
2022-12-08$1.40/sh+20,000$28,000→ 223,146 total
Holdings
- 25,573(indirect: See footnote)
Voting Common Shares, no par value per share
- 21,070(indirect: By Spouse)
Voting Common Shares, no par value per share
Footnotes (3)
- [F1]Includes 4,146 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan, 29,829 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan, 164,890 voting common shares held by Michael Giuffre and his wife jointly and 61,360 voting common shares held by Michael Giuffre individually.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.41 to $1.44, inclusive. The reporting person undertakes to provide to DiaMedica Therapeutics Inc., any security holder of DiaMedica Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2) to this Form 4.
- [F3]These voting common shares are held by 424822 Albert Ltd, of which Michael Giuffre has sole voting and dispositive power.
Documents
Issuer
DiaMedica Therapeutics Inc.
CIK 0001401040
Entity typeother
Related Parties
1- filerCIK 0001759822
Filing Metadata
- Form type
- 4
- Filed
- Dec 11, 7:00 PM ET
- Accepted
- Dec 12, 4:34 PM ET
- Size
- 8.8 KB